ArticleACS chemical biology2015

Illuminating the molecular mechanisms of tyrosine kinase inhibitor resistance for the FGFR1 gatekeeper mutation: the Achilles' heel of targeted therapy.

Christal D Sohl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.